GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (STU:BKD) » Definitions » Cyclically Adjusted FCF per Share

Bruker (STU:BKD) Cyclically Adjusted FCF per Share : €1.15 (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bruker Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bruker's adjusted free cash flow per share for the three months ended in Jun. 2024 was €-0.148. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.15 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Bruker's average Cyclically Adjusted FCF Growth Rate was 1.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 14.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bruker was 93.10% per year. The lowest was 6.80% per year. And the median was 12.60% per year.

As of today (2024-09-21), Bruker's current stock price is €60.70. Bruker's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was €1.15. Bruker's Cyclically Adjusted Price-to-FCF of today is 52.78.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bruker was 98.24. The lowest was 33.02. And the median was 53.14.


Bruker Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Bruker's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Cyclically Adjusted FCF per Share Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.65 0.83 1.02 1.10

Bruker Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.14 1.10 1.13 1.15

Competitive Comparison of Bruker's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Bruker's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted Price-to-FCF falls into.



Bruker Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bruker's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.148/132.5538*132.5538
=-0.148

Current CPI (Jun. 2024) = 132.5538.

Bruker Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.016 100.428 0.021
201412 0.298 99.070 0.399
201503 0.116 99.621 0.154
201506 -0.048 100.684 -0.063
201509 0.236 100.392 0.312
201512 0.750 99.792 0.996
201603 -0.120 100.470 -0.158
201606 0.049 101.688 0.064
201609 0.150 101.861 0.195
201612 0.470 101.863 0.612
201703 0.123 102.862 0.159
201706 -0.149 103.349 -0.191
201709 0.133 104.136 0.169
201712 0.492 104.011 0.627
201803 0.182 105.290 0.229
201806 0.148 106.317 0.185
201809 0.088 106.507 0.110
201812 0.626 105.998 0.783
201903 0.020 107.251 0.025
201906 -0.042 108.070 -0.052
201909 0.211 108.329 0.258
201912 0.625 108.420 0.764
202003 0.026 108.902 0.032
202006 -0.049 108.767 -0.060
202009 0.357 109.815 0.431
202012 0.930 109.897 1.122
202103 0.402 111.754 0.477
202106 -0.004 114.631 -0.005
202109 0.042 115.734 0.048
202112 0.639 117.630 0.720
202203 0.353 121.301 0.386
202206 -0.393 125.017 -0.417
202209 0.080 125.227 0.085
202212 0.874 125.222 0.925
202303 0.395 127.348 0.411
202306 -0.066 128.729 -0.068
202309 0.109 129.860 0.111
202312 1.091 129.419 1.117
202403 0.003 131.776 0.003
202406 -0.148 132.554 -0.148

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Bruker  (STU:BKD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bruker's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=60.70/1.15
=52.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bruker was 98.24. The lowest was 33.02. And the median was 53.14.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bruker Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Bruker's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.